Short term outcome following acute phase switch among P2Y(12) inhibitors in patients presenting with acute coronary syndrome treated with PCI: A systematic review and meta-analysis including 22,500 patients from 14 studies

INTRODUCTION: The efficacy and safety of switching P2Y(12) receptor antagonists in patients admitted for acute coronary syndrome (ACS) remain unclear. We assessed the short-term clinical outcomes (in-hospital and within 30 days) of switching P2Y(12) inhibitor (P2Y(12)I) drugs versus maintaining the...

Descripción completa

Detalles Bibliográficos
Autores principales: Cerrato, Enrico, Bianco, Matteo, Bagai, Akshay, De Luca, Leonardo, Biscaglia, Simone, Luciano, Alessia, Destefanis, Paola, Quadri, Giorgio, Meynet, Ilaria, Gravinese, Carol, Chinaglia, Alessandra, Goodman, Shaun G., Pozzi, Roberto, Campo, Gianluca, Varbella, Ferdinando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288462/
https://www.ncbi.nlm.nih.gov/pubmed/30560202
http://dx.doi.org/10.1016/j.ijcha.2018.11.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288462/
https://www.ncbi.nlm.nih.gov/pubmed/30560202
http://dx.doi.org/10.1016/j.ijcha.2018.11.008

Ejemplares similares